Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Human Umbilical Cord Mesenchymal Stem Cells(MSCs) Transplantation for on Prognosis of Acute Cerebral Infarction Patients

NCT04093336 is registered in ClinicalTrials.gov with Shanghai East Hospital as lead sponsor.

NCT NCT04093336
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04093336 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Human Umbilical Cord Mesenchymal Stem Cells(MSCs) Transplantation for on Prognosis of Acute Cerebral Infarction Patients
Lead sponsor
Shanghai East Hospital
Phase
Phase 1/2
Overall status
Unknown status
Start date
January 13, 2019
Completion date
December 30, 2024
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute stroke, brain infarction, cerebral infarction, infarction, anterior cerebral artery, infarction, middle cerebral artery, infarction, pca, infarction, posterior circulation, brain, stroke, ischemic